RPPApipe
RPPApipe analyzes reverse-phase protein array (RPPA) data to perform preprocessing, statistical analysis, clustering, and pathway mapping for proteomic studies.
Key Features:
- Data Preprocessing: Cleans and normalizes raw RPPA data, addressing background noise and variability inherent in protein array datasets.
- Statistical Analysis: Applies advanced statistical methods to identify significant patterns and differences in protein expression.
- Clustering: Implements clustering algorithms to group similar protein expression profiles and identify subgroups.
- Pathway Analysis: Maps protein expression data onto known biological pathways to assess functional and mechanistic impacts.
- RPPA-specific Support: Provides analytical approaches tailored to the reverse-phase protein array platform distinct from gene-centered microarray analyses.
Scientific Applications:
- Cancer Biology: Enables investigation of protein expression and signaling alterations in cancer samples using RPPA data.
- Drug Discovery: Supports evaluation of drug effects on protein expression and pathway modulation.
- Proteomic Studies: Facilitates analysis of protein dynamics and biomarker discovery from complex proteomic datasets.
Methodology:
Implemented using R/Bioconductor; includes preprocessing (background correction and normalization), statistical analysis, clustering algorithms, and pathway analysis; embedded within the ZBIT Bioinformatics Toolbox (a customized Galaxy instance).
Topics
Details
- License:
- GPL-3.0
- Tool Type:
- library, web application
- Operating Systems:
- Linux, Windows, Mac
- Programming Languages:
- R
- Added:
- 5/22/2018
- Last Updated:
- 12/10/2018
Operations
Publications
Eichner J, Heubach Y, Ruff M, Kohlhof H, Strobl S, Mayer B, Pawlak M, Templin MF, Zell A. RPPApipe: A pipeline for the analysis of reverse-phase protein array data. Biosystems. 2014;122:19-24. doi:10.1016/j.biosystems.2014.06.009. PMID:24951946.
PMID: 24951946
Funding: - Federal Ministry of Education and Research (BMBF, Germany): 0315384C, 0315756
- Innovative Medicine Initiative Joint Undertaking (IMI JU): 115001